Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Post

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 13, 2009
New bioabsorbable septal repair implant for percutaneous closure of a patent foramen ovale: short-term results of a single-centre experienceB J L Van den Branden, M C Post, W Jaarsma, et al.
Acta Clinica Belgica|December 4, 2008
New-onset and persistent migraine early after percutaneous atrial septal defect closure disappear at follow-upA Voet, J G L M Luermans, V Thijs, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 30, 2008
Complications and mid-term outcome after percutaneous patent foramen ovale closure in patients with cryptogenic strokeJ G L M Luermans, M C Post, H W M Plokker, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 7, 2016
PulmoCor: national registry for pulmonary hypertensionM C Post, A P Van Dijk, E S Hoendermis, et al.
Journal of Interventional Cardiology|March 7, 2020
Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults: More than 800 Patient-Years of Follow-UpR J R Snijder, L E Renes, D Bosshardt, et al.
Lung|October 5, 2019
Bosentan or Macitentan Therapy in Chronic Thromboembolic Pulmonary Hypertension?M C J van Thor, L Ten Klooster, R J Snijder, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 23, 2020
Safety of macitentan in sarcoidosis-associated pulmonary hypertension: a case-seriesH Mathijssen, M P Huitema, A L M Bakker, et al.
Neurology|January 26, 2006
Embolization of pulmonary arteriovenous malformations and decrease in prevalence of migraineM C Post, V Thijs, W J Schonewille, et al.
Respiratory Medicine|March 1, 2022
Four-year survival rate in pulmonary sarcoidosis with extensive pulmonary hypertension screeningM P Huitema, H Mathijssen, A L M Bakker, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|August 12, 2020
New developments in adult congenital heart diseaseB J Bouma, G T Sieswerda, M C Post, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 13, 2009
New bioabsorbable septal repair implant for percutaneous closure of a patent foramen ovale: short-term results of a single-centre experienceB J L Van den Branden, M C Post, W Jaarsma, et al.
Acta Clinica Belgica|December 4, 2008
New-onset and persistent migraine early after percutaneous atrial septal defect closure disappear at follow-upA Voet, J G L M Luermans, V Thijs, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 30, 2008
Complications and mid-term outcome after percutaneous patent foramen ovale closure in patients with cryptogenic strokeJ G L M Luermans, M C Post, H W M Plokker, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 7, 2016
PulmoCor: national registry for pulmonary hypertensionM C Post, A P Van Dijk, E S Hoendermis, et al.
Journal of Interventional Cardiology|March 7, 2020
Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults: More than 800 Patient-Years of Follow-UpR J R Snijder, L E Renes, D Bosshardt, et al.
Lung|October 5, 2019
Bosentan or Macitentan Therapy in Chronic Thromboembolic Pulmonary Hypertension?M C J van Thor, L Ten Klooster, R J Snijder, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 23, 2020
Safety of macitentan in sarcoidosis-associated pulmonary hypertension: a case-seriesH Mathijssen, M P Huitema, A L M Bakker, et al.
Neurology|January 26, 2006
Embolization of pulmonary arteriovenous malformations and decrease in prevalence of migraineM C Post, V Thijs, W J Schonewille, et al.
Respiratory Medicine|March 1, 2022
Four-year survival rate in pulmonary sarcoidosis with extensive pulmonary hypertension screeningM P Huitema, H Mathijssen, A L M Bakker, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|August 12, 2020
New developments in adult congenital heart diseaseB J Bouma, G T Sieswerda, M C Post, et al.
Pageof 7